These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16174984)

  • 1. Translational research in prognostic profiling in colorectal cancer.
    de Noo ME; Liefers GJ; Tollenaar RA
    Dig Surg; 2005; 22(4):276-81. PubMed ID: 16174984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies.
    D'Onofrio G; Jauch E; Jagoda A; Allen MH; Anglin D; Barsan WG; Berger RP; Bobrow BJ; Boudreaux ED; Bushnell C; Chan YF; Currier G; Eggly S; Ichord R; Larkin GL; Laskowitz D; Neumar RW; Newman-Toker DE; Quinn J; Shear K; Todd KH; Zatzick D;
    Ann Emerg Med; 2010 Nov; 56(5):551-64. PubMed ID: 21036295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic methodologies and their application in colorectal cancer research.
    Ikonomou G; Samiotaki M; Panayotou G
    Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. dbCPCO: a database of genetic markers tested for their predictive and prognostic value in colorectal cancer.
    Savas S; Younghusband HB
    Hum Mutat; 2010 Aug; 31(8):901-7. PubMed ID: 20506273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current concepts of prognostic factors for colorectal cancer].
    Beliaeva AV; Moiseenko AB; Guliaev AV
    Vopr Onkol; 2011; 57(3):279-85. PubMed ID: 21882596
    [No Abstract]   [Full Text] [Related]  

  • 8. The changing scenario in laboratory medicine and the role of laboratory professionals in translational medicine.
    Plebani M
    Clin Chim Acta; 2008 Jul; 393(1):23-6. PubMed ID: 18423398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene profiling in early stage disease.
    Midgley R; Rasul K; Al Salama H; Kerr DJ
    Cancer J; 2010; 16(3):210-3. PubMed ID: 20526098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
    Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
    Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on cancer diagnosis in Malaysia: current status.
    Looi LM; Zubaidah Z; Cheah PL; Cheong SK; Gudum HR; Iekhsan O; Ikram SI; Jamal R; Mak JW; Othman NH; Puteri JN; Rosline H; Sabariah AR; Seow HF; Sharifah NA;
    Malays J Pathol; 2004 Jun; 26(1):13-27. PubMed ID: 16190103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.
    Ransohoff DF
    J Clin Epidemiol; 2007 Dec; 60(12):1205-19. PubMed ID: 17998073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
    von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
    Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients.
    Vendrell E; Ribas M; Valls J; Solé X; Grau M; Moreno V; Capellà G; Peinado MA
    Int J Oncol; 2007 May; 30(5):1099-107. PubMed ID: 17390011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New prognostic markers in colorectal cancer].
    Nielsen HJ; Brünner NA; Thorlacius-Ussing O; Kehlet H
    Ugeskr Laeger; 1998 Aug; 160(32):4617-21. PubMed ID: 9719740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.